We report a prospective, nationwide cohort evaluating the safety and effectiveness of CT-P13.
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy
Maconi, Giovanni;Di Sabatino, Antonio
;Massari, Alessandro;
2018-01-01
Abstract
We report a prospective, nationwide cohort evaluating the safety and effectiveness of CT-P13.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
